Abstract
Plants are the source of a large spectrum of phytochemicals, and the combined and concerted action of biologically active compounds lead to the potential beneficial properties of each plant matrix. A great attention is being addressed over the years toward herbs and medicinal plants. Dragon’s Blood is a reddish resin oil extracted from Croton lechleri tree. It has been extensively used by indigenous cultures of the Amazon River since ancient times due to the beneficial nutraceutical and pharmaceutical properties. This perspective aims at providing a current framework on Dragon’s Blood with focus on antioxidant properties for nutraceuticals and pharmaceuticals in a novelty integrated and multidisciplinary manner, highlighting the current knowledge, the main research lines, and emerging strategies. A literature quantitative research analysis approach was applied as starting point. The literature search was carried out by means of the Scopus database; 365 documents have been retrieved in the year range from 1854 to 2021, and a total of 269 terms were identified. Among the top-recurring keywords appear: unclassified drug, nonhuman, plant extract/s, Dragon’s Blood, dracaena, Dragon Blood, chemistry, human, animal/s, plant resin. Source, chemical composition, potential nutraceutical, and therapeutical applications of Dragon’s Blood are discussed here. The anti-inflammatory, wound healing, antidiarrheals, anticancer, antirheumatic, antiseptic, and antioxidant activities identified in the Dragon’s Blood extracts can open novel perspectives for its use in food and pharmaceutical industries. While different bioactive compounds have already been identified in Dragon’s Blood extract, only a few studies can be found in literature.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
1 Introduction
Plants are the source of a large spectrum of phytochemicals, and the combined and concerted action of biologically active compounds lead to the potential beneficial properties of each plant matrix (Santini and Novellino 2017; Durazzo et al. 2018, 2020). A great attention is being addressed along the years toward the traditional medicine (Fitzgerald et al. 2020; Yeung et al. 2020) by exploiting the features, properties, and applications of herbs and medicinal plants (Naz et al. 2015; Begum et al. 2020; Durazzo et al. 2021a, b; Sharifi-Rad et al. 2021, Durazzo et al. 2022], taking into account biodiversity and sustainability (Guarino and Pignatti 2010; Pignatti and Cipriani 2010; Pignatti 2013; Attorre et al. 2018; Durazzo and Lucarini 2021; Chung et al. 2021).
In this context, Dragon’s Blood tree (Croton lechleri) is particularly interesting for its beneficial properties associated since centuries to the red exudate produced, which is popularly known as grade blood or blood of water (Guerra et al. 2022). This species belongs to the Euphorbiaceae family and is found in the Amazon region in Brazil. It usually has a length of 5–6 m but can reach up to 20 m. What differentiates it from other trees is that a reddish sap is exuded when its bark is cut. Such sap is called blood of the dragon and is vastly used since centuries as a popular holistic medicine (Sun et al. 2019; Salazar-Gomez et al. 2022).
This perspective aims at providing a current framework on Dragon’s Blood with focus on antioxidant properties for nutraceuticals and pharmaceuticals in a novelty integrated and multidisciplinary manner, highlighting the current knowledge, the main research lines, and emerging strategies.
A literature quantitative research analysis approach was applied as starting point, to give a current snapshot of the current trend raised in the international research context by this topic. A search throughout the Scopus online database has been carried out by means of the string TITLE-ABS-KEY (“dragon’s blood*”), and the “full records and cited references” were exported and processed using the VOSviewer software (version 1.6.16, 2020; www.vosviewer.com, accessed on 8 December 2021) (Waltman et al. 2010).
The search returned 365 publications covering the time range from 1854 to 2021, and a total of 269 terms were identified and visualized as a term map in Fig. 1. Figure 1 allows for the identification of the main terms correlated to Dragon’s Blood, and also identifies the main existing research lines focused on this topic. It is interesting to observe that among the top-recurring keywords, appear: unclassified drug, nonhuman, plant extract/s, dragon’s blood, dracaena, dragon blood, chemistry, human, animal/s, plant resin.
The most recent review is focused on the advanced research progress on anti-tumor effect of Chinese Dragon’s Blood (Tian et al. 2021), whereas the most cited review is published by Gupta et al. in the Journal of Ethnopharmacology and it is addressed on botany, chemistry, and therapeutic uses of Dragon's Blood (Gupta et al. 2008) and in 2017, Bayerl published an interesting “Editorial” document on Dragon’s Blood (Bayerl 2017).
The main subject areas explored are as follows: Pharmacology, Toxicology and Pharmaceutics, Biochemistry, Genetics and Molecular Biology, Chemistry, Medicine, Agricultural and Biological Sciences, Environmental Science, and others.
In the context of the environmental impact and sustainability perspective, it is worth mentioning the works on sustainable land use management needed to conserve the Dragon's Blood tree of Socotra Island representing a vulnerable endemic umbrella species (Maděra et al. 2019); the socio economic roles of Dragon’s Blood in participative rehabilitation of degraded forest and land (Letari et al. 2019); the Dragon’s Blood secretion and its ecological significance (Jura-Morawiec et al. 2016, 2022).
Dragon’s Blood can be used in the treatment of gastric diseases and infections, and it is also capable of healing wounds. Native people use the sap of the plant on burns and wounds to stop bleeding, speed up healing, and protect from infections (Jiang et al. 2017; Sun et al. 2019).
Dragon's Blood is one of the strongest healing agents known, it dries quickly when applied, and forms a second skin that promotes collagen formation and fibroblasts chemotaxis (Namjoyan et al. 2015). Croton lechleri ethanolic extract also exhibited antibacterial activity against superinfected skin ulcers in Colombian hospitalized patients (Corrales-Ramirez et al. 2013), and it had a highly significant bacterial inhibition when compared with the standard treatment in the clinic.
Different bioactive compounds were reported from Dragon’s Blood resin (Jaronski et al. 2017). It is an astringent latex with cellulose and Dragon’s Blood resin as active ingredients. It is composed of alcohol esters resinous, tannins (dimethylcedrusine, etc.), polyphenols (gallic acid, etc.), alkaloids (Namjoyan et al. 2015), proanthocyanidins, steroids (sitosterols, catechins), saponins, and lignans (Fan et al. 2014; Luo et al. 2015). Among the identified compounds, there are some that are linked directly with the properties of the Dragon’s Blood. According to the literature, the alkaloid taspine proved to be the main active compound responsible for wound healing. It is associated with the formation of collagen, promoting healing by migrating fibroblasts to the injury site on the skin (Vaisberg et al. 1989; Namjoyna et al. 2015; Canedo-Téxon et al. 2019). Besides taspine, flavonoid compounds with antioxidant properties act as reducing agents, eliminating free radicals, since they donate hydrogen to free radicals. Flavans, flavanones, polymeric flavonoids, chromogen ketones, and flavanols can also be acknowledged, since they are secondary plant metabolites involved in the defense against ultraviolet radiation or aggression by pathogens, contributing to plant pigmentations and antioxidant. Additionally, these compounds also demonstrated benefits in the prevention of various diseases associated with oxidative stress, such as cancer, cardiovascular, and neurodegenerative diseases (Escobar et al. 2018). About proanthocyanidins, Rossi et al. (2011) showed that it is responsible for 90% of the dry weight of Dragon’s Blood, characterized by its antioxidant and antibacterial properties. Regarding compounds in lower concentration, the lignan 3´,4-O-dimethylcedrusin is highlighted due to its participation in wound healing and there are korbein-A and korbein-B (De Martino et al. 2008). The main chemical compounds of Dragon’s Blood are listed in Table 1.
2 Extraction and properties
Trees known as “dragon” or “dragon’s blood” have shared healing properties, although they belong to distinct botanical families. Croton lechleri (Euphorbiaceous) is found in Peru, Ecuador, Colombia, and northern Brazil (Rossi et al. 2011). Also, Croton urucurana are usually sighted in the southeast, mid-west, and southern regions of Brazil, as well as in Argentina and Uruguay. Both species are relatives and their respective sap has a similar pharmacological activity. In the state of Minas Gerais (Brazil), Dragon’s Blood is often called “water bleeds”, as it grows near rivers and ponds (Martins et al. 2016). A large volume of latex was extracted indiscriminately in Colombia, Ecuador, and Peru, with the falling of the trees (Aguirre et al. 2001). As an example, in 1998, 50.607 L of Croton lechleri latex were exported mainly to Europe, United States, and Japan (Galy et al. 2000). Currently, the latex collection for commercial purposes occurs on a smaller scale that supplies regional communities. The Dragon’s Blood latex extraction is similar to seringals, by cutting the trunk at breast height in a V-shape, then a reddish-colored sap exudes. Also, indigenous-influenced extraction is highlighted, where the incisions are made in tree trunks and the drops of latex are collected. This process begins when the tree aged 6–7 years or when its DAP (diameter to breast height) reaches approximately 25–27 cm. An incision is made at 1.30 m of the soil and the recommended extraction is at morning during the full moon for 5–9 h. This method produces regularly an average of 2.0–3.5 L of latex (Aguirre et al. 2001; Osakada 2009). Latex conservation can be done by adding sugarcane liquor to prevent the product from crystallizing. The final product should be packed in an airtight container and stored in refrigerated places. This latex has from 3 to 6 months of storage life (Vásquez and Bach 2015). Dragon’s Blood has interesting properties for medicinal applications (Sun 2019). It can treat scarring by stimulating skin rejuvenation, which explains its antioxidant property. Other characteristics of Dragon’s Blood are its antibacterial, antiviral, and anti-inflammatory activity, and can be exploited for several medicinal uses (Fig. 2).
2.1 Wound healing
The Dragon’s Blood healing properties are associated to the two most active components present in the sap, taspine and dimethylcedrusin. Both are efficient in healing, but also in the treatment of gastric and duodenal ulcers (Sun et al. 2019). A process of taspine isolation and its use in wound healing, acting on various mechanisms that lead to skin regeneration, in varicose ulcers and bedsores has been described (Vaisberg et al. 1989; Namjoyan et al. 2016; Guerra et al. 2022). Dragon’s Blood polyphenols and proanthocyanidins are potent antioxidants that could act against free radicals that cause skin aging (Escobar et al. 2018). In cosmetics, these compounds increase the collagen synthesis reducing the wrinkles formation and promote skin rejuvenation, and also protect the skin against UV rays. It is very effective in the treatment of acne and can be combined with the essential oil of Cypress (Cupressus Sempervirens) or Pitanga (Eugenia Uniflora). Polyphenols also play an important role in healing and eliminating free radicals, mainly proanthocyanidins, which stimulate wound contraction and healing. In this way, the gel produced from the latex of Croton lechleri called also “Sangre de Drago”, has a therapeutic effect (Namjoyan et al. 2015; Apaza Ticona 2021). A summary of the healing properties is shown in Fig. 3.
2.2 Antiviral and antibacterial activities
The latex of Croton lechleri Dragon’s Blood plant has antibacterial and antiviral properties through its secondary metabolites belonging to phenol, terpenoids, alkaloids, leptins, polypeptides (Gupta and Gupta 2011; Bayerl 2017) groups, among others. The pure extract of the plant Croton lechleri Mull Arg. has secondary metabolites with antibacterial and antiviral properties as displayed in Fig. 4, including 2,4,6-trimethoxyphenol, 1,3,5-trimethoxybenzene, korberin A and B, crolechinic acid, proanthocyanidins, catechins, epicatechins, gallocatechins, galloepicatechins, flavonols phenol, terpenoids, alkaloids, leptins and polypeptides (Gupta and Gupta 2011; Lopes at al. 2013; Bayerl 2017) groups. Experiments have shown that sap inhibits the action of various types of viruses, such as herpes simplex, hepatitis virus (Olson 2015), influenza and parainfluenza (due to the influenza virus), cytomegalovirus, and respiratory syncytial viruses (Vilchez and Braulio 2018). The Shaman Pharmaceuticals Company developed a drug, named Virend®, containing antiviral compounds extracted and isolated from the Dragon’s Blood bark and resin for the treatment of herpes. They also developed an oral drug called Provir® for the treatment of respiratory viral infections (King and Tempesta 1994; Snell 2001). Croton lechleri has a large community of endophytic fungi with great antibacterial potential against bacteria pathogenic to humans, especially against Gram-positive bacteria (Ferreira et al. 2021; Sebastiao 2018). It showed antibacterial effect on Staphylococcus aureus ATCC 43300 in concentrations above 77%. The antimicrobial activity of Dragon’s Blood resin obtained from Dracaena cinnabari Balf f. dichloromethane extract was attributed to the high concentration of phenolics, flavonoids, and flavonols, being proposed as a natural food preservative (Gupta and Gupta 2011).
2.3 Anti-inflammatory activity
The intragastric administration of Dragon’s Blood in carrageenan-inflamed or sciatic nerve-injured rats demonstrated its potent anti-inflammatory and analgesic effects by inhibiting hyperalgesia and paw edema, and by reducing the expression of cyclooxygenase-2 protein or preprotachykinin-A mRNA (Li et al. 2012) blocks the activation of nerve fibers that release pain signals to the brain, and functions as an antalgic. The analgesic effect of topical administration of Dragon’s Blood, which was reported to last up to 6 h, has been exploited in gels containing 1–3% of resin in the treatment of relief of rheumatism arthritis and arthrosis, as well as against pain caused by herpes zoster, inflammation of the trigeminal nerve, bursitis, twists, and fibromyalgia (Pieters et al 1993). Resin can be formulated in creams or gels (in percentages of 3–5% of the total) with anti-inflammatory essential oils (e.g., copaiba, oregano, ginger, or wintergreen) that are also analgesics and can potentiate the bioactivities of Dragons’ Blood. Immunomodulatory activity of this resin has also been demonstrated by affecting the activated T cells. In low doses, it is a phagocytosis inhibitor, and in higher doses has antioxidant and an activating effect of phagocytosis. It shows the ability to inhibit the proliferation of leukemic cells and cytostatic activity against KB and V-79 tumors. In veterinary, Dragon’s Blood is also very efficient, treating skin infections, warts, wounds, abscesses, and otitis (Dietrich 2018).
2.4 Antioxidant and anticancer activities
Antioxidants are substances that block the harmful effect of free radicals. Natural antioxidants are phenolic compounds that are formed by benzene groups and hydroxyl substituents, which have oxy-reducing properties and the ability to stabilize intermediate compounds (Sandoval et al. 2006). The evaluation of combined and concerted action of bioactive compounds gives the measurement of antioxidant properties and indicator of health status (Durazzo 2017; Santini and Cicero 2020). The Dragon’s Blood is an exceptionally high and stable antioxidant (Escobar et al. 2018; Pona et al. 2019). The antioxidant capacity of Dragon’s Blood in the gastric mucosa has been studied in experimental animals. It was concluded that the bioactive extract presented a positive effect through the gastric route, confirmed by the lower lipid peroxidation. It has also been reported that 75% ethanol extract from Chinese Dragon’s Blood suppressed cell growth and promoted apoptosis in human hepatoma HepG2 and SK-HEP-1 cells (Chen et al. 2020). Using RNA interference, the authors demonstrated the anti-hepatoma activity of the ethanolic extract partially through downregulation of Smad3, one of major members in TGF-β/Smad signaling pathway.
3 Current applications
The most relevant applications of Dragon’s Blood are listed in Table 2. The development of formulations for the topical administration of Dragon’s Blood using biopolymers is seldom reported in the literature. The production of a dressing containing silk fibroin and an aqueous solution with polyethylene oxide (PEO) of 1000 [KDa] at 3% (w/v) Dragon’s Blood at 2% (v/v) has been described (Melo et al. 2018). The sample is characterized by continuous fibers with the presence of porous granules, which is one of the main requirements of dressings to accelerate cell migration. Also, tissue healing and antibacterial activity of chitosan and polyvinyl alcohol were tested with the addition of hydroalcoholic solution of Croton lechleri formulated in chitosan and polyvinyl alcohol semi-solid for tissue healing, and tested its antimicrobial activity against S. aureus, resulting a minimal inhibitory concentration of 0.025 g/10 mL (León and Santiago 2007). Chitosan and pullulan have been proposed to be used as local delivery systems for active ingredients from plant extracts for the treatment against periodontal pathogen microorganisms (Rodriguez-Garcia et al. 2010). Thickness of chitosan films was on average of 0.03 mm and for pullulan of 0.07 mm. Five plant extracts were tested, and among them was Croton lechleri. The results revealed that both biopolymers with added plant extracts have antibacterial activity and can be used as bio-adhesive film against periodontopathogens tested.
The stability of Dragon’s Blood sap was studied considering several storage conditions, under different environments of temperature and relative humidity (Escobar et al. 2018). In addition, an accelerated aging treatment was performed, subjecting the lyophilized Dragon’s Blood sap to irradiation with UV light, and the effect of these stress conditions on its antioxidant activity was also evaluated. The results demonstrated that the concentration of the sap constituent’s changes at different storage conditions. For example, the storage conditions were studied in a range of temperature from 4 to 21 ºC, and different conditions of relative humidity (0, 23, 44, and 56%). The presence of moisture was evaluated with respect to the Dragon’s Blood degradation. Regarding the temperature, no significant effect was detected in the range studied (4 ºC and 21 ºC at a 0% relative humidity). However, applying UV light irradiation, a reduction of 20% of the sap concentration was observed. The antioxidant activity remained stable under the studied storage conditions (under different temperature and relative humidity) (Escobar et al. 2018). The high stability observed for Dragon’s Blood sap can confer interesting characteristics in various industrial products, such as food, pharmaceuticals, nutraceuticals or cosmetics, paints or paper products, being possibly used as an antioxidant or as an ingredient.
Ingestion of crude extracts or tea formulations of Croton lechleri may cause mild nausea, bitter taste or diarrhea (Pona et al. 2019). The use of Dragon’s Blood as a healing agent in concentrations of 0.1% and concentrations of 0.001% caused negative effects on the reproductive tract of Wistar Rats, since it caused a decrease in the values of membrane integrity, acrosome, and cell viability of sperm (Schmuch et al. 2013). To test and evaluate the potential toxic, cytotoxic, and mutagenic/genotoxic of Croton lechleri, a test with Allium cepa was performed by diluting 0.5, 1.0, 2.0, and 2.5 mL of the extract in 250 mL of water, using root growth, mitotic index, and the presence of micronuclei as parameters. It was observed that all the concentrations used of Croton lechleri inhibited the root growth of the roots of Allium cepa, evidencing its toxic potential. There was also a decrease in the mitotic index, mainly at the concentration of 2.5 mL, indicating cytotoxicity. In addition to cytotoxicity, the mutagenic potential was observed through the high micronucleus index, showing that the “dragon’s sap” should be used with caution (De Almeida et al. 2019). In another study, to analyze long-term Dragon’s Blood toxicity, rabbits were administered Guangxi Dragon’s Blood at rates of 3.0 and 1.5 g/kg body weight, once a day for 90 days. It has been observed that the Dragon’s Blood did not cause changes in the animal’s pathological state, and had no significant effect on blood erythrocytes and leukocytes number, alanine aminotransferase, urea nitrogen, or weight. There was no functional damage to the liver or kidney. In the pathological examination under optical microscope, except for some expansion of the tiny blood vessel between myocardial cells, there was no damage to the liver, lungs, kidney, intestine or the adrenal glands, thus indicating that the use of Dragon’s Blood did not show toxic reactions (Fan et al. 2014).
Application of nanotechnologies to plants’ extracts of nutraceutical interest (Daliu et al. 2019; Zielińska et al. 2019; Souto et al. 2020a; Durazzo et al. 2021a, b) represents a key issue, such as the preparation, characterization, and dissolution characteristics of Dragon’s Blood extract nanosuspensions (Wang et al. 2019); the silver nanoparticle’s synthesis by Dragon’s Blood resin ethanol extract and antiradiation activity (Wang et al. 2019); the assessment of bioreducing and stabilizing potential of Dragon's Blood resin extract in synthesis of silver containing nanoparticles (Hasan et al. 2015); surface-enhanced Raman scattering study of organic pigments using silver and gold nanoparticles prepared by pulsed laser ablation (Hasan et al. 2013; Fazio et al. 2013). Safety aspects and procedures should be taken into proper account in view of an optimal use of these techniques aimed to improve perspective applications of this important vegetal matrix (Zielińska et al. 2020; Souto et al. 2020b).
4 Conclusion
The latex of Croton lechleri or Dragon’s Blood, which is known to be used in the Amazonic region, has potential application in medicine in the treatment of many diseases. The resin offers huge potential, and studies are needed to improve the extraction, to purify the compounds isolated from Dragon’s Blood, and assess completely quality and control aspects. Also, the correct administration of Croton lechleri to ensure proper, safe, and responsible uses and applications should be investigated.
Data availability
Not applicable.
References
Aguirre MRA, Botina PJR, Arias ODA, Forero PL (2001) Especies promisorias de la Amazonía: conservación, manejo y utilización del germoplasma. Corporación Colombiana De Investigación Agropecuaria 4:193–197
Apaza Ticona L, Rumbero Sánchez A, Sánchez Sánchez-Corral J, Iglesias Moreno P, Ortega Domenech M (2021) Anti-inflammatory, pro-proliferative and antimicrobial potential of the compounds isolated from Daemonorops draco (Willd.) Blume. J Ethnopharmacol 268:113668. https://doi.org/10.1016/j.jep.2020.113668
Attorre F, Pignatti S, Spada F, Caella L, Agrillo E (2018) Introduction: vegetation science and the habitats directive: approaches and methodologies of a never-ending story. Rend Fis Acc Lincei 29:233–235. https://doi.org/10.1007/s12210-018-0716-5
Bayerl CD (2017) Drachenblut. Aktuelle Dermatologie 43(04):127. https://doi.org/10.1055/s-0043-104813
Begum G, Dastagir G, Rauf A, Bawazeer S, Ur Rahman K, Fawzy Ramadan M (2020) Pharmacognostic characteristics and phytochemical profile of various parts of Parthenium hysterophorus. Rend Fis Acc Lincei 31:853–872. https://doi.org/10.1007/s12210-020-00911-z
Canedo-Téxon A, Ramón-Farias F, Monribot-Villanueva JL, Villafán E, Alonso-Sánchez A, Pérez-Torres CA, Ángeles G, Guerrero-Analco JA, Ibarra-Laclette E (2019) Novel findings to the biosynthetic pathway of magnoflorine and taspine through transcriptomic and metabolomic analysis of Croton draco (Euphorbiaceae). BMC Plant Biol 19:560. https://doi.org/10.1186/s12870-019-2195-y
Chen X, Zhao Y, Yang A, Tian Y, Pang D, Sun J, Tang L, Huang H, Wang Y, Zhao Y, Pegfei T, Zhongdong H, Li J (2020) Chinese Dragon’s blood EtOAc extract inhibits liver cancer growth through downregulation of Smad3. Front Pharmacol 11:669. https://doi.org/10.3389/fphar.2020.00669
Chung V, Ho L, Leung TH, Wong C (2021) Designing delivery models of traditional and complementary medicine services: a review of international experiences. British Med Bull 137(1):70–81. https://doi.org/10.1093/bmb/ldaa046
Corrales Ramírez L, Castillo Castañeda A, Melo Vargas A (2013) Evaluación del potencial antibacterial in vitro de Croton lechleri frente a aislamientos bacterianos de pacientes con úlceras cutáneas. J Nova 11:51–63
Daliu P, Santini A, Novellino E (2019) From pharmaceuticals to nutraceuticals: bridging disease prevention and management. Expert Rev Clin Pharmacol 12(1):1–7. https://doi.org/10.1080/17512433.2019.1552135
De Almeida FKV, de Novais VP, Salvi JDO, Marson RF (2019) Avaliação tóxica, citotóxica e mutagênica/genotóxica de um extrato comercial de sangue do dragão (Croton lechleri). Revista Fitos 13(1):29–37. https://doi.org/10.17648/2446-4775.2019.605
De Marino S, Gala F, Zollo F, Vitalini S, Fico G, Visioli F, Iorizzi M (2008) Identification of minor secondary metabolites from the latex of croton lechleri (Muell-Arg) and evaluation of their antioxidant activity. Molecules 13:1219–1229. https://doi.org/10.3390/molecules13061219
Diedrich C (2018) Otimização multivariada de extração de compostos bioativos em folhas, casca e resíduos de seiva de Croton lechleri. 135 f. Dissertação (Mestrado em Tecnologia de Processos Químicos e Bioquímicos) - Universidade Tecnológica Federal do Paraná, Pato Branco, Brasil.
Durazzo A (2017) Study approach of antioxidant properties in foods: update and considerations. Foods 6(3):17. https://doi.org/10.3390/foods6030017
Durazzo A, Lucarini M (2021) Environmental, ecological and food resources in the biodiversity overview: health benefits. Life 11:1228. https://doi.org/10.3390/life11111228
Durazzo A, D’Addezio L, Camilli E, Piccinelli R, Turrini A, Marletta L, Marconi S, Lucarini M, Lisciani S, Gabrielli P, Gambelli L, Aguzzi A, Sette S (2018) From plant compounds to botanicals and back: a current snapshot. Molecules 23:1844. https://doi.org/10.3390/molecules23081844
Durazzo A, Lucarini M, Santini A (2020) Nutraceuticals in human health. Foods 9:370. https://doi.org/10.3390/foods9030370
Durazzo A, Lombardi-Boccia G, Santini A, Lucarini M (2021a) Dietary antioxidants and metabolic diseases. Int J Mol Sci 22(22):12558. https://doi.org/10.3390/ijms222212558
Durazzo A, Lucarini M, Nazhand A, Silva AM, Souto SB, Guerra F, Severino P, Zaccardelli M, Souto EB, Santini A (2021b) Astragalus (Astragalus membranaceus Bunge): botanical, geographical, and historical aspects to pharmaceutical components and beneficial role. Rend Fis Acc Lincei 32:625–642. https://doi.org/10.1007/s12210-021-01003-2
Durazzo A, Lucarini M, Nazhand A, Coêlho A, Souto EB, Arcanjo DDR, Santini A (2022) Rhodiola rosea: main features and its beneficial properties. Rend Fis Acc Lincei 33:71–82. https://doi.org/10.1007/s12210-022-01055-y
Escobar JD, Prieto C, Pardo-Figuerez M, Lagaron JM (2018) Dragon’s blood sap: storage stability and antioxidant activity. Molecules 23:2641. https://doi.org/10.3390/molecules23102641
Fan J-Y, Yi T, Sze-To C-M, Zhu L, Peng W-L, Zhang Y-Z, Zhao Z-Z, Chen H-B (2014) A systematic review of the botanical, phytochemical and pharmacological profile of Dracaena cochinchinensis, a plant source of the ethnomedicine “dragon’s blood.” Molecules 19:10650–10669. https://doi.org/10.3390/molecules190710650
Fazio E, Trusso S, Ponterio RC (2013) Surface-enhanced Raman scattering study of organic pigments using silver and gold nanoparticles prepared by pulsed laser ablation. Appl Surf Sci 272:36–41. https://doi.org/10.1016/j.apsusc.2012.02.070
Ferreira EMS, Corrêia TM, da Silva JFM, Pimenta RS (2021) Endophytic fungi associated with medicinal plants of Amazonian forest. In: Rosa LH (ed) Neotropical endophytic fungi: diversity, ecology, and biotechnological applications. Springer International Publishing, Cham, pp 177–197. https://doi.org/10.1007/978-3-030-53506-3_9
Fitzgerald M, Heinrich M, Booker A (2020) Medicinal plant analysis: a historical and regional discussion of emergent complex techniques front. Pharmacol 10:1480. https://doi.org/10.3389/fphar.2019.01480
Galy S, Rengifo E, Oliver YH (2000) Factores de la organización del mercado de las plantas medicinales en Iquitos – Amazonía Peruana. Folia Amazónica 11:139–158
Guarino R, Pignatti S (2010) Diversitas and biodiversity: the roots of a twenty-first century myth. Rend Fis Acc Lincei 21:351–357. https://doi.org/10.1007/s12210-010-0104-2
Guerra junior JI, Ferreira MRA, de Oliveira AM, Soares LAL (2022) Croton sp.: a review about Popular Uses, Biological Activities and Chemical Composition. Research, Society and Development [S. l.] 11(2) p. e57311225306. https://doi.org/10.33448/rsd-v11i2.25306
Gupta D, Gupta RK (2011) Bioprotective properties of Dragon’s blood resin: In vitro evaluation of antioxidant activity and antimicrobial activity. BMC Complement Altern Med 11:13. https://doi.org/10.1186/1472-6882-11-13
Gupta D, Bleakley B, Gupta RK (2008) Dragon’s blood: botany, chemistry and therapeutic uses. J Ethnopharmacol 115:361–380. https://doi.org/10.1016/j.jep.2007.10.018
Hasan M, Teng Z, Iqbal J, Awan U, Meng S, Dai R, Qing H, Deng Y (2013) Assessment of bioreducing and stabilizing potential of Dragon’s blood (Dracaena Cochinchinensis, Lour. S. C. Chen) resin extract in synthesis of silver nanoparticles. Nanosci Nanotechnol Lett 5:780–784. https://doi.org/10.1166/nnl.2013.1600
Hasan M, Iqbal J, Awan U, Saeed Y, Ranran Y, Liang Y, Dai R, Deng Y (2015) Mechanistic study of silver nanoparticle’s synthesis by Dragon’s blood resin ethanol extract and antiradiation activity. J Nanosci Nanotechnol 15:1320–1326. https://doi.org/10.1166/jnn.2015.9090
Jaronski ST, Mascarin GM (2017) Mass production of fungal entomopathogens. In: Microbial control of insect and mite pests, Lacey, L.A. United States, chap 9. Academic Press, Cambridge, MA, United States, pp 141–155. https://doi.org/10.1016/B978-0-12-803527-6.00009-3
Jiang X-W, Qiao L, Liu L, Zhang B-Q, Wang X-W, Han Y-W, Yu W-H (2017) Dracorhodin perchlorate accelerates cutaneous wound healing in Wistar rats. Evid Based Complement Alternat Med 2017:8950516. https://doi.org/10.1155/2017/8950516
Jura-Morawiec J, Tulik M (2016) Dragon’s blood secretion and its ecological significance. Chemoecology 26:101–105. https://doi.org/10.1007/s00049-016-0212-2
Jura-Morawiec J, Marcinkiewicz J, Caujapé-Castells J (2022) Unraveling the role of dragon’s blood in the undisturbed growth of dragon trees. Trees. https://doi.org/10.1007/s00468-022-02349-2
King SR, Tempesta MS (1994) From shaman to human clinical trials: the role of industry in ethnobotany, conservation and community reciprocity. Ciba Found Symp 185:197–206. https://doi.org/10.1002/9780470514634.ch14. (discussion 206-113)
León K, Santiago J (2007) Propiedades antimicrobianas de películas de quitosano-alcohol polivinílico embebidas en extracto de sangre de grado. Revista De La Sociedad Química Del Perú 73:158–165
Lestari S, Premono BT, Kunarso A (2019) Socio Economic Roles of Dragon Blood in Participative Rehabilitation of Degraded Forest and Land. IOP Conference Series: Earth and Environmental Science 298: 012033. https://doi.org/10.1088/1755-1315/298/1/012033
Li YS, Wang JX, Jia MM, Liu M, Li XJ, Tang HB (2012) Dragon’s blood inhibits chronic inflammatory and neuropathic pain responses by blocking the synthesis and release of substance P in rats. J Pharmacol Sci 118:43–54. https://doi.org/10.1254/jphs.11160fp
Lopes TV, Félix SR, Schons SdV, Nobre MdO (2013) Dragon’s blood (Croton lechleri Mull., Arg.): an update on the chemical composition and medical applications of this natural plant extract. A review Revista Brasileira de Higiene e Sanidade Animal 7:167–191. https://doi.org/10.5935/1981-2965.20130016
Luo Y, Shen HY, Zuo WJ, Wang H, Mei WL, Dai HF (2015) A new steroidal saponin from Dragon’s blood of Dracaena cambodiana. J Asian Nat Prod Res 17:409–414. https://doi.org/10.1080/10286020.2014.967229
Maděra P, Volařík D, Patočka Z, Kalivodová H, Divín J, Rejžek M, Vybíral J, Lvončík S, Jeník D, Hanáček P, Amer AS, Vahalík P (2019) Sustainable land use management needed to conserve the Dragon’s blood tree of Socotra Island, a vulnerable endemic umbrella species. Sustainability 11(13):3557. https://doi.org/10.3390/su11133557
Martins CM, Hamanaka EF, Hoshida TY, Sell AM, Hidalgo MM, Silveira CS, Poi WR (2016) Dragon’s blood sap (Croton Lechleri) as storage medium for avulsed teeth. In vitro study of cell viability. Braz Dent J 27:751–756. https://doi.org/10.1590/0103-6440201600987
Melo G, Villacís Núñez CN, Vizuete K, Arroyo C, Narváez C (2018) Usos de la Sangre de drago (Croton Lechleri Müll) en apósitos para heridas crónicas obtenidos mediante la técnica de Electrospinning. Congreso de Ciencia y Tecnología ESPE 13: 85–88. https://doi.org/10.24133/cctespe.v13i1.813
Namjoyan F, Kiashi F Moosavi ZB, Saffari F, Makhmalzadeh BS (2015) Efficacy of Dragon’s blood cream on wound healing: a randomized, double-blind, placebo-controlled clinical trial. J Tradit Complement Med 6:37–40. https://doi.org/10.1016/j.jtcme.2014.11.029
Namjoyan F, Kiashi F, Moosavi ZB, Saffari F, Makhmalzadeh BS (2016) Efficacy of Dragon’s blood cream on wound healing: a randomized, double-blind, placebo-controlled clinical trial. J Tradit Complement Med 6:37–40. https://doi.org/10.1016/j.jtcme.2014.11.029
Naz R, Anis M, Aref IM (2015) Management of cytokinin–auxin interactions for in vitro shoot proliferation of Althaea officinalis L.: a valuable medicinal plant. Rend Fis Acc Lincei 26:323–334. https://doi.org/10.1007/s12210-015-0424-3
Olson S (2015) An analysis of the biopesticide market now and where it is going. Outlooks on Pest Management 26:203–206. https://doi.org/10.1564/v26_oct_04
Osakada A (2009) Master Dissertation. Desenvolvimento inicial de sangue-de-dragão (Croton lechleri MÜLL. ARG.) sob diferentes classes de solos, corretivos e níveis de luminosidade na Amazônia Central. In: Aspectos Generales De La Planificación Tributaria En Venezuela, Universidade Federal do Amazonas, (Mestrado em Fisiologia vegetal, Fitogeografia, Sistemática e Taxonomia vegetal, Botânica aplicada, Biologia vegetal) - Instituto Nacional de Pesquisas da Amazônia, Manaus, Brasil.
Pieters L, de Bruyne T, Claeys M, Vlietinck A, Calomme M, vanden Berghe D (1993) Isolation of a dihydrobenzofuran lignan from South American Dragon’s blood (Croton spp.) as an inhibitor of cell proliferation. J Nat Prod 56:899-906. https://doi.org/10.1021/np50096a013
Pignatti S (2013) A discussion on the foundations of environmental ethics. Rend Fis Acc Lincei 24:89–94. https://doi.org/10.1007/s12210-013-0226-4
Pignatti S, Cipriani M (2010) The diversity of plants in a text from the seventeenth century. Rend Fis Acc Lincei 21:343–350. https://doi.org/10.1007/s12210-010-0105-1
Pona A, Cline A, Kolli SS, Taylor SL, Feldman SR (2019) Review of future insights of Dragon’s blood in dermatology. Dermatol Ther 32(2):12786. https://doi.org/10.1111/dth.12786
Rodriguez-Garcia A, Galan-Wong LJ, Arevalo-Niño K (2010) Development and in vitro evaluation of biopolymers as a delivery system against periodontopathogen microorganisms. Acta Odontologica Latinoamericana AOL 23:158–163
Rossi D, Guerrini A, Maietti S, Bruni R, Paganetto G, Poli F, Scalvenzi L, Radice M, Saro K, Sacchetti G (2011) Chemical fingerprinting and bioactivity of Amazonian Ecuador Croton lechleri Müll. Arg. (Euphorbiaceae) stem bark essential oil: a new functional food ingredient? Food Chem 126:837–848. https://doi.org/10.1016/j.foodchem.2010.11.042
Salazar-Gómez A, Alonso-Castro AJ (2022) Medicinal plants from Latin America with wound Healing activity: ethnomedicine, phytochemistry, preclinical and clinical studies—a review. Pharmaceuticals 15(9):1095. https://doi.org/10.3390/ph15091095
Sandoval M, Ayala S, Oré R, Loli A, Huamán Ó, Valdivieso R, Béjar E (2006) Capacidad antioxidante de la sangre de grado (Croton palanostigma) sobre la mucosa gástrica, en animales de experimentación. Anales De La Facultad De Medicina 67:199–205
Santini A, Cicero N (2020) Development of food chemistry, natural products, and nutrition research: targeting new frontiers. Foods 9(4):482. https://doi.org/10.3390/foods9040482
Santini A, Novellino E (2017) To nutraceuticals and back: rethinking a concept. Foods 6(9):74. https://doi.org/10.3390/foods6090074
Schuch MS, Ferreira CER, Nobre MO, Lopes TV, Tillmann MT, Corcini CD (2013) Avaliação dos Efeitos Toxicológicos no Trato Reprodutivo de Ratos Wistar (Rattus norvegicus) submetidos ao uso de sangue de Dragão. In: XXII Congresso de Iniciação Científica da Universidade Federal de Pelotas, 18–22nd November, Prédio Campus Porto, Pelotas, Rio Grande do Sul, Brazil.
Sebastiao LPV, Erlan KBdA, Sandra ALR, Atilon VdA, Renildo MdC, Clarice MC (2018) Antibacterial activity of endophytic fungi isolated from Croton lechleri (Euphorbiaceae). J Med Plants Res 12:170–178. https://doi.org/10.5897/jmpr2018.6581
Sharifi-Rad J, Quispe C, Herrera-Bravo J, Muhammad Akram M, Abbaass, W, Semwal P, Painuli S, Dmitry Konovalov A, Alfred MA, Anil Kumar NV, Imran M, Nadeem, M, Sawicka B, Pszczółkowski P, Bienia B, Barbaś, P, Mahmud S, Durazzo A, Lucarini M, Santini A, Martorell M, Calina D (2021) Phytochemical Constituents, Biological Activities, and Health-Promoting Effects of the Melissa officinalis Oxidative Medicine and Cellular Longevity, Article ID 6584693, 20 pages. https://doi.org/10.1155/2021/6584693
Snell NJC (2001) New treatments for viral respiratory tract infections—opportunities and problems. J Antimicrob Chemother 47(3):251–259. https://doi.org/10.1093/jac/47.3.251
Souto EB, Silva GF, Dias-Ferreira J, Zielinska A, Ventura F, Durazzo A, Lucarini M, Novellino E, Santini A (2020a) Nanopharmaceutics: part II—production scales and clinically compliant production methods. Nanomaterials 10:455. https://doi.org/10.3390/nano10030455
Souto EB, Silva GF, Dias-Ferreira J, Zielinska A, Ventura F, Durazzo A, Lucarini M, Novellino E, Santini A (2020b) Nanopharmaceutics: part I—clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU. Pharmaceutics 12:146. https://doi.org/10.3390/pharmaceutics12020146
Sun J, Liu J-N, Fan B, Chen X-N, Pang D-R, Zheng J, Zhang Q, Zhao Y-F, Xiao W, Peng-Fei T, Song YL, Li J (2019) Phenolic constituents, pharmacological activities, quality control, and metabolism of Dracaena species: a review. J Ethnopharmacol 244:112138. https://doi.org/10.1016/j.jep.2019.112138
Tian YY, Yang AL, Chen XN, Li JQ, Tang LM, Huang HM, Liu YX, Qiu HL, Ouyang LS, Li J, Tu PF, Hu ZD (2021) Research progress on anti-tumor effect of Chinese Dragon’s blood. Zhongguo Zhong Yao Za Zhi 46(8):2037–2044. https://doi.org/10.19540/j.cnki.cjcmm.20201215.601
Vaisberg AJ, Milla M, Planas MC, Cordova JL, de Agusti ER, Ferreyra R, Mustiga MC, Carlin L, Hammond GB (1989) Taspine is the cicatrizant principle in Sangre de Grado extracted from Croton lechleri. Planta Med 55:140–143. https://doi.org/10.1055/s-2006-961907
Vásquez QFGJG, Bach LBM (2015) Efecto cicatrizante del gel elaborado del látex de Croton lechleri “Sangre de Drago.” Rev Cient Cienc Méd 18:10–16
Vílchez JJC, Braulio CHC (2018) Evaluación del efecto antibacteriano in vitro del látex de Croton lechleri “sangre de grado” frente a Staphylococcus aureus atcc 25923. Conocimiento Paral El Desarrollo 9(1):129–136
Waltman L, van Eck NJ, Noyons ECM (2010) A unified approach to mapping and clustering of bibliometric networks. J Informet 4:629–635. https://doi.org/10.1016/j.joi.2010.07.002
Wang LF, Chen XN, Li J, Tu PF, Wang JL (2019) Preparation, characterization and dissolution characteristics of dragon’s blood extract nanosuspensions. Zhongguo Zhong Yao Za Zhi 44:2236–2243. https://doi.org/10.19540/j.cnki.cjcmm.20181221.005
Yeung A, Heinrich M, Kijjoa A, Tzvetkov NT, Atanasov AG (2020) The ethnopharmacological literature: an analysis of the scientific landscape. J Ethnopharmacol 250:112414. https://doi.org/10.1016/j.jep.2019.112414
Zielińska A, Ferreira NR, Durazzo A, Lucarini M, Cicero N, El Mamouni S, Silva AM, Nowak I, Santini A, Souto EB (2019) Development and optimization of alpha-pinene-loaded solid lipid nanoparticles (SLN) using experimental factorial design and dispersion analysis. Molecules 24:2683. https://doi.org/10.3390/molecules24152683
Zielińska A, Costa B, Ferreira MV, Miguéis D, Louros JMS, Durazzo A, Lucarini M, Eder P, Chaud MV, Morsink M, Willemen N, Severino P, Santini A, Souto EB (2020) Nanotoxicology and nanosafety: safety-by-design and testing at a glance. Int J Environ Res Public Health 17:4657. https://doi.org/10.3390/ijerph17134657
Acknowledgements
Not applicable.
Funding
Open access funding provided by Università degli Studi di Napoli Federico II within the CRUI-CARE Agreement. This research was funded by Banco do Nordeste (grant FUNDECI/2016.0015), Coordenação Aperfeiçoamento de Pessoal de Nivel Superior (CAPES) and Fundação de Ámparo à Pesquisa do Estado de Sergipe (FAPITEC) (PROCESSO: 88887.159533/2017-00 extração, encapsulação e caracterização de bioativos para o interesse biotecnologico). Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 301964/2019-0 Chamada 06/2019, and Chamada CNPq nº 01/2019).
Author information
Authors and Affiliations
Contributions
ISAP, KAOC, LAFS, and NGK have contributed to the methodology, formal analysis, investigation, resources, software, data curation, and drafting of the original manuscript, CMPY, VOCC, ML, AD, AS, EBS, and PS have contributed to the formal analysis, data curation, writing review and editing of the manuscript, conceptualization, project administration, supervision, and funding acquisition. All authors have made a substantial contribution to the work and have approved its publication.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Institutional review board
Not applicable.
Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Peres, I.S.A., Conceição, K.A.O., Silva, L.A.F. et al. Dragon’s Blood: antioxidant properties for nutraceuticals and pharmaceuticals. Rend. Fis. Acc. Lincei 34, 131–142 (2023). https://doi.org/10.1007/s12210-022-01122-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12210-022-01122-4